The deal-by-deal investor has taken a stake to help grow the provider of clinical insourcing services to the NHS.
Bay Tree Private Equity has completed an investment in London-based Medicare Insourcing Services, a provider of clinical insourcing services to the NHS.
Financial terms have not been disclosed.
Founded in 2018, Medicare Insourcing Services partners with NHS Trusts to provide advanced practitioner-led insourcing solutions throughout the UK. It works with more than 50 NHS Trusts and provides them with additional clinical capacity, which helps to reduce waiting times. To date, its services have helped more than three million patients across the country.
The business has now received new investment from Bay Tree Private Equity, a UK-based private equity deal-by-deal investor that focuses on the healthcare services market in addition to a number of other sectors, and partners with their management teams to support value creation.
The debt funding package has been structured by FRP Corporate Finance to suit Medicare’s market position and asset-light, cash-generative model. It will be used to support chief executive Scott Littlefield and his management team as they embark on the next phase of the business’s growth strategy alongside Stephen Collier, who has been appointed as chair as part of this transaction.
“Medicare operates in an attractive and growing segment of the UK healthcare market, providing essential additional capacity to the NHS. The business has developed a strong reputation for clinical quality and delivery,” said Edward Cottrell, partner at Bay Tree Private Equity.
The private equity firm’s recent deals include acquisitions of ABL Healthcare and Hawco.
